- Home
- EOLS vs BRR Comparison
EOLS vs BRR Comparison
Compare EOLS & BRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOLS
- BRR
- Stock Information
- Founded
- EOLS 2012
- BRR 2024
- Country
- EOLS United States
- BRR United States
- Employees
- EOLS N/A
- BRR N/A
- Industry
- EOLS Biotechnology: Pharmaceutical Preparations
- BRR Blank Checks
- Sector
- EOLS Health Care
- BRR Finance
- Exchange
- EOLS Nasdaq
- BRR Nasdaq
- Market Cap
- EOLS 412.0M
- BRR 342.8M
- IPO Year
- EOLS 2018
- BRR N/A
- Fundamental
- Price
- EOLS $6.73
- BRR $10.07
- Analyst Decision
- EOLS Strong Buy
- BRR
- Analyst Count
- EOLS 5
- BRR 0
- Target Price
- EOLS $21.25
- BRR N/A
- AVG Volume (30 Days)
- EOLS 2.3M
- BRR 354.1K
- Earning Date
- EOLS 08-05-2025
- BRR 01-01-0001
- Dividend Yield
- EOLS N/A
- BRR N/A
- EPS Growth
- EOLS N/A
- BRR N/A
- EPS
- EOLS N/A
- BRR N/A
- Revenue
- EOLS $277,941,000.00
- BRR N/A
- Revenue This Year
- EOLS $33.42
- BRR N/A
- Revenue Next Year
- EOLS $33.18
- BRR N/A
- P/E Ratio
- EOLS N/A
- BRR N/A
- Revenue Growth
- EOLS 17.15
- BRR N/A
- 52 Week Low
- EOLS $5.71
- BRR $10.05
- 52 Week High
- EOLS $17.82
- BRR $10.42
- Technical
- Relative Strength Index (RSI)
- EOLS 33.84
- BRR N/A
- Support Level
- EOLS $6.21
- BRR N/A
- Resistance Level
- EOLS $6.74
- BRR N/A
- Average True Range (ATR)
- EOLS 0.45
- BRR 0.00
- MACD
- EOLS -0.16
- BRR 0.00
- Stochastic Oscillator
- EOLS 27.49
- BRR 0.00
About EOLS Evolus Inc.
Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.
About BRR Columbus Circle Capital Corp I Class A Ordinary Shares
Columbus Circle Capital Corp I is a blank check company.